Cleviprex Injectable Emulsion
Chiesi USA is recalling Cleviprex (clevidipine injectable emulsion) 50 mg/100 mL vials due to a lack of assurance of sterility.
Healthcare providers should immediately examine their inventory, quarantine any affected product, and contact the manufacturer for return instructions.
Recall at a glance
- Quantity recalled
- 44280 vials
Why it was recalled
Chiesi USA is recalling Cleviprex (clevidipine injectable emulsion) due to a lack of assurance of sterility. The affected product is supplied in 50 mg/100 mL (0.5 mg/mL) single-use vials.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
CLEVIPREX (clevidipine injectable emulsion)
- Lot code
- 1239521, 1237454, 2027
- Strength
- 50 mg
- NDC / UPC
- NDC 10122-611-10
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Sterility Failure recalls
Other recent recalls from Chiesi USA, Inc.
Editorial summary by Recall Canary · summary updated 2026-07-15 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification